EMERSON ERIK C. (Chief Executive Officer) received a stock award from APIMEDS PHARMACEUTICALS US, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/20/2025ACC: 0001474506-25-000099
DirectorOfficer· Chief Executive Officer
Since Mar 2025
+1.10M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.10M acquired
Non-Derivative Transactions1
Common Stock, par value $0.01 per share
Direct
Shares
+750K
Price / share
—
Trade value
—
% of position
New position
5/16/2025
0.00→750K
Total
Net shares
+750K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share Direct | 5/16/2025 | A · Award | +750K | — | — | New position | 0.00 | 750K |
| Total | +750K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock, par value $0.01 per share
347.28K shares
Shares
+347.28K
Strike price
1.81
Held after
347.28K
Exercisable
—
5/16/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock, par value $0.01 per share347.28K shares | 5/16/2025 | A · Award | +347.28K | 1.81 | — | 347.28K |